• Epilepsy is a neurological disorder that shows itself in the form of seizures. Seizures are the disruption of electrical activity of the brain can last from 30 seconds to two minutes. Physical signs of a seizure include uncontrolled convulsions, repeated blinking of the eyes, difficulty breathing or talking, and loss of bladder control.



    Diagnosis is given if someone has two or more unprovoked seizures in the span of 24 hours. It may be caused by genetic inheritance, infections, or a change in brain structure from brain injury and affects 65 million people worldwide of all ages. 34% of sudden deaths in children are caused by Sudden Unexpected Death in Epilepsy.



    Epilepsy may be characterized by a group of features to identify epilepsy syndromes. Common types of Epilepsy Syndromes include: West syndrome, Doose syndrome, Lennox-Gastaut syndrome, and Sturge-Weber syndrome.



    Most epileptic patients are either prescribed long-term drug therapy that runs the risk of serious side effects, try dietary or behavioral therapies, or undergo brain surgery when medicine does not work. Medical marijuana is a potential treatment for epilepsy as research studies imply that CBD can act as an anticonvulsant and can significantly reduce seizures without psychoactive effects. Rigorous clinical trials for medical cannabis in epilepsy are continuing to run in hopes of achieving FDA approval.


     
  • Category
    Critical Ailments
  • Created
    Thursday, 30 November 2017
  • Group admin
    CBIS

Become an iCannabinoid Ambassador

GET INV

Observational Studies

PART

Activity Stream

Osaruname Osayi-Osazuwa shared Raymond C. Dabney's status 1 week ago

Attending the GHC Summit is how I got involved with iCannabinoid. I had just finished my Masters thesis about prescription drug abuse and misuse and the rest is history.

Next month May 24-26 is the 2019 Harvard GHC Summit !!

Our team will be be attending for the 3rd year in a row and are very excited as every year it...
Show more

The Company is in the process of getting a third-party, independent valuation to establish the value of its CBN patent for the Canadian, U.S.,... Show more

Notifications

Events

Sorry, we currently have no events.
View All Events